$158,000 price tag for new ALS drug reignites anger at Big Pharma
Fox News
A new drug that slows the progression of ALS is exorbitantly expensive, one again raising anger at the pharmaceutical industry for locking life-changing drugs behind high costs.
As a result, getting on a drug that slows progression quickly is vital to many patients, but the high price tag set by Amylyx causes insurance companies to lock the drug behind a lengthy application process, and the drug is sometimes cost-prohibitive for patients even with coverage, according to the Associated Press. Anders Hagstrom is a reporter with Fox News Digital covering national politics and major breaking news events. Send tips to Anders.Hagstrom@Fox.com, or on Twitter: @Hagstrom_Anders.
"When someone’s lifespan is measured in months, making people go through these multiple rounds of review is just cruel," said Neil Thakur, the chief mission officer at the ALS Association.
Critically endangered whale seen off California coast: 'Every sighting is incredibly valuable to us'
In a rare sighting recently, the endangered North Pacific right whale was spotted off the coast of California by a marine wildlife team near Cordell Bank National Marine Sanctuary.